Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance

Stefano Bassetti1, Lea Wolfisberg, Barbara Jaussi

  • 1Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland.

Abstract

Insights

Injection heroin maintenance programs showed lower Staphylococcus aureus carriage rates compared to oral methadone programs. This suggests aseptic needle use may not increase S. aureus carriage in these patients.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Addiction Medicine

Background:

  • Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) are significant pathogens.
  • Carriage rates of S. aureus can vary among different populations, including injection drug users (IDUs).
  • Opiate maintenance programs offer different delivery methods (injection vs. oral) which may influence carriage rates.

Purpose of the Study:

  • To compare S. aureus and MRSA carriage prevalence in IDUs receiving injection heroin versus oral methadone.
  • To identify predictors of S. aureus carriage within these IDU groups.

Main Methods:

  • A survey was conducted at two university psychiatric clinic opiate maintenance programs.
  • Participants included 94 IDUs from an injection heroin program and 70 IDUs from an oral methadone program.
  • Data on S. aureus and MRSA carriage were collected and analyzed.

Main Results:

  • IDUs in the injection heroin program had significantly lower S. aureus carriage rates (39.4%) compared to those in the oral methadone program (60%).
  • Nasal carriage rates were also significantly lower in the injection heroin group (22.3%) versus the oral methadone group (42.9%).
  • Treatment in the oral methadone program was the sole independent predictor of S. aureus carriage.

Conclusions:

  • Aseptic needle use in injection heroin programs did not appear to increase S. aureus carriage rates.
  • Further research is needed to determine if lower S. aureus carriage in this group translates to reduced S. aureus infections.
  • These findings have implications for harm reduction strategies in addiction treatment.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...